DK: Primære forskningsområder: Lungekræft, oligometastaser, kliniske studier, stereotaktisk strålebehandling, palliativ strålebehandling, åndedrætstilpasning og billedvejledning.
UK: Primary research areas: lung cancer, oligometastatic disease, clinical trials, stereotactic radiotherapy, palliative radiotherapy, respiratory adaptation and image guidance.
Arbejdsgrupper- WP4 - Adaptive Radiation Therapy
- IP5 - Lung
- IP15 - Oligometastatic disease
- WP9 - Palliative radiotherapy
- WP8 - Reirradiation
- Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trial Br J Radiol. 2019 Dec;92(1104):20190569 2019
- Incorporating NTCP into Randomized Trials of Proton Versus Photon Therapy. Int J Part Ther. 2019 Winter;5(3):24-32. 2019
- Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours Radiother Oncol . 2022 Jun;171:53-61 2022
- Metal artefact reduction for accurate tumour delineation in radiotherapy. Radiother Oncol. 2018 Mar;126(3):479-486 2017
- Long term safety and visibility of a novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancer Clin Transl Radiat Oncol. 2018 Aug 2;13:24-28 2018
- Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer Br J Radiol. 2018 Dec;91(1092):20180236 2018
- Advanced dose calculation algorithms in lung cancer radiotherapy: Implications for SBRT and locally advanced disease in deep inspiration breath hold. Phys Med. 2018 Dec;56:50-57 2018
- A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer J Thorac Oncol. 2018 Apr;13(4):559-567 2018
- The dosimetric effect of residual breath-hold motion in pencil beam scanned proton therapy - An experimental study. Radiother Oncol. 2019 May;134:135-142 2019
- Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption? Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):747-755 2020
- Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy Radiother Oncol. 2020 Jun;147:178-185 2020
- Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations. PLoS One. 2020 Apr 28;15(4):e0231884 2020
- Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studies Acta Oncol. 2020 Jun;59(6):628-635 2020
- 18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial J Nucl Med. 2021 May 10;62(5):628-635 2021
- The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy J Thorac Oncol. 2021 Jul;16(7):1200-1210 2021
- osimetric influence of deformable image registration uncertainties on propagated structures for online daily adaptive proton therapy of lung cancer patients Radiother Oncol. 2021 Jun;159:136-143 2021
- Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study Tech Innov Patient Support Radiat Oncol. 2022 Jul 16;23:8-14 2022
- Patterns of care in oligometastatic disease: the clinicians' perspective Acta Oncol. 2022 Sep;61(9):1148-1151 2022
- Synthetic 4DCT(MRI) lung phantom generation for 4D radiotherapy and image guidance investigations Med Phys. 2022 May;49(5):2890-2903 2022
- Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer . Tech Innov Patient Support Radiat Oncol. 2022 Apr 12;22:30-36 2022